Prostate cancer Posts - Page 42 of 80 on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Local therapies improve survival in men with metastatic prostate cancer at diagnosis

Posted by on Jun 30, 2016 in Prostate cancer | 0 comments

In a nutshell This study investigated the benefit of local therapies as first-line interventions for metastatic prostate cancer. Authors reported improved survival with radiation and surgery among men with metastatic prostate cancer at diagnosis. Some background Metastatic prostate cancer is cancer that has spread to distant parts of the body. The...

Read More

Combining chemotherapy and hormone therapy early for metastatic prostate cancer

Combining chemotherapy and hormone therapy early for metastatic prostate cancer

Posted by on Jun 27, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the safety and effectiveness of androgen deprivation therapy (ADT) plus docetaxel (Taxotere) compared to ADT alone for metastatic prostate cancer. Researchers reported increased progression-free survival and overall survival when ADT was combined with docetaxel. Some background ADT is a type of hormone therapy...

Read More

Decline in circulating tumor cells during treatment associated with better survival

Decline in circulating tumor cells during treatment associated with better survival

Posted by on Jun 27, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the link between circulating tumor cells (CTCs) and treatment outcome in metastatic castration-resistant prostate cancer (mCRPC). Authors reported better survival outcomes for mCRPC patients with a significant decline in CTC count during treatment.  Some background Metastatic castration-resistant prostate...

Read More

Now less invasive: Imaging-guided radiation techniques for prostate cancer

Posted by on Jun 20, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of two forms of imaging-guided radiation techniques for prostate cancer. Researchers reported more favorable outcomes with intensity modulated radiation therapy (IMRT) than with 3-dimensional conformal radiation therapy (3DCRT). Some background Radiation therapy is a common treatment...

Read More

Potential predictor of treatment outcomes for metastatic castration-resistant prostate cancer

Potential predictor of treatment outcomes for metastatic castration-resistant prostate cancer

Posted by on Jun 17, 2016 in Prostate cancer | 0 comments

In a nutshell This study analyzed predictors of treatment outcomes for metastatic castration-resistant prostate cancer (mCRPC). Researchers concluded that testosterone levels before treatment can help predict overall survival in men with mCRPC.  Some background Hormone therapy is the standard of care for advanced prostate cancer, including...

Read More

Different doses and combinations of external beam radiation therapy examined

Different doses and combinations of external beam radiation therapy examined

Posted by on Jun 17, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared different external beam radiation therapy (EBRT) approaches for localized prostate cancer. Authors reported high effectiveness with higher doses of radiation therapy, particularly when hormone therapy was added to treatment. However, these combinations were also associated with the highest rate of side effects. Some...

Read More

After Cancer Treatment: Living Out The Cure

After Cancer Treatment: Living Out The Cure

Posted by on Jun 13, 2016 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 2 comments

When you’re 8 years old, jumping rope, playing dolls, swinging on swing sets and doing homework are girlhood pursuits.  Discovering  “Lumpy Luey” in your left chest wall isn’t. In 1978, Stephanie Dodds’ way of  coping with the diagnosis of Ewing Sarcoma was to give it a name and focus on “getting rid of it.”...

Read More

Searching for overweight men with low-risk prostate cancer undergoing active surveillance

Posted by on Jun 13, 2016 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial aims to evaluate the benefit of a diet and exercise program in overweight men with low-risk prostate cancer. The main outcome to be investigated is a change in blood sugar metabolism in prostate cancer cells. The trial is recruiting in Seattle (Washington), USA. The details Low-risk prostate cancer is often managed...

Read More

A Review of Prostate Cancer Prognostic Factors

A Review of Prostate Cancer Prognostic Factors

Posted by on Jun 12, 2016 in Prostate cancer | 0 comments

  Prognostic factors, including blood tests and radiographic scans, can help establish a patient’s prognosis and determine a treatment path. Experts from MD Anderson Cancer Center, Drs. Jeri Kim and Sumit Subudhi, review factors that are associate with prostate cancer and discuss research underway that could lead to more personalized...

Read More